NDC product
Double Antibiotic
NDC 21922-092 · Encube Ethicals, Inc.
Key facts
| Product NDC | 21922-092 |
|---|---|
| Proprietary name | Double Antibiotic |
| Nonproprietary name | bacitracin zinc polymyxin b sulfate |
| Substances | BACITRACIN ZINC, POLYMYXIN B SULFATE |
| Dosage form | OINTMENT |
| Route | TOPICAL |
| Labeler | Encube Ethicals, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M004 |
| Pharmacologic classes | Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| Marketing start | Mar 6, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: